A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, Liu J, Beasley J, McCaw P, Zhang H, Young S, Groth J, Wang Q, Locasale JW, Gao X, Tang DG, Dong X, He Y, George D, Hu H, Huang J.
Xu L, et al. Among authors: mccaw p.
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2012748118. doi: 10.1073/pnas.2012748118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33753479
Free PMC article.